Danaher Q3 2026 Earnings: The $6.6B Quarter That Masimo Built
Danaher Q3 2026 revenue rose 8.3% to $6.55B, mostly on Masimo; $291M of tax benefits lifted net income 36%, just 4% without them. EPS guide: $8.57–$8.62.
#danaher
Danaher
Financial analysis and earnings reports for Danaher Corporation (DHR), the Washington, D.C.-based life sciences and diagnostics company behind Cytiva, Beckman Coulter, Cepheid and Masimo